Respiratory syncytial virus infections in children and adults

被引:44
作者
Collins, CL [1 ]
Pollard, AJ [1 ]
机构
[1] Univ Oxford, John Radcliffe Hosp, Dept Paediat, Oxford Vaccine Grp, Oxford OX3 9DU, England
关键词
D O I
10.1053/jinf.2001.1016
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Respiratory syncytial virus is the leading cause of hospital admission for lower respiratory tract infection in young children and appears to be responsible for a significant burden of disease in adults, particularly the elderly and the immunocompromised. In this review, we describe the epidemiology, diagnosis and clinical manifestations of infection attributed to this virus. We also consider current therapeutic and prophylactic options and appraise strategies for vaccination that are in clinical trials. (C) 2002 The British Infection Society.
引用
收藏
页码:10 / 17
页数:8
相关论文
共 71 条
[1]  
BEEM M, 1967, J IMMUNOL, V98, P1115
[2]   International variation in the management of infants hospitalized with respiratory syncytial virus [J].
Behrendt, CE ;
Decker, MD ;
Burch, DJ ;
Watson, PH .
EUROPEAN JOURNAL OF PEDIATRICS, 1998, 157 (03) :215-220
[3]   Pathogenesis of RSV lower respiratory tract infection: implications for vaccine development [J].
Brandenburg, AH ;
Neijens, HJ ;
Osterhaus, ADME .
VACCINE, 2001, 19 (20-22) :2769-2782
[4]   BRONCHIOLITIS IN TROPICAL SOUTH-INDIA [J].
CHERIAN, T ;
SIMOES, EAF ;
STEINHOFF, MC ;
CHITRA, K ;
JOHN, M ;
RAGHUPATHY, P ;
JOHN, TJ .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1990, 144 (09) :1026-1030
[5]   INTERFERON-ALPHA-2A FOR TREATMENT OF BRONCHIOLITIS CAUSED BY RESPIRATORY SYNCYTIAL VIRUS [J].
CHIPPS, BE ;
SULLIVAN, WF ;
PORTNOY, JM .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1993, 12 (08) :653-658
[6]  
Connor E, 1997, PEDIATRICS, V99, P93
[7]   The use of palivizumab monoclonal antibody to control an outbreak of respiratory syncytial virus infection in a special care baby unit [J].
Cox, RA ;
Rao, P ;
Brandon-Cox, C .
JOURNAL OF HOSPITAL INFECTION, 2001, 48 (03) :186-192
[8]   Immune responses of infants to infection with respiratory viruses and live attenuated respiratory virus candidate vaccines [J].
Crowe, JE .
VACCINE, 1998, 16 (14-15) :1423-1432
[9]   A COMPARISON IN CHIMPANZEES OF THE IMMUNOGENICITY AND EFFICACY OF LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS (RSV) TEMPERATURE-SENSITIVE MUTANT VACCINES AND VACCINIA VIRUS RECOMBINANTS THAT EXPRESS THE SURFACE GLYCOPROTEINS OF RSV [J].
CROWE, JE ;
COLLINS, PL ;
LONDON, WT ;
CHANOCK, RM ;
MURPHY, BR .
VACCINE, 1993, 11 (14) :1395-1404
[10]   CURRENT APPROACHES TO THE DEVELOPMENT OF VACCINES AGAINST DISEASE CAUSED BY RESPIRATORY SYNCYTIAL VIRUS (RSV) AND PARAINFLUENZA VIRUS (PIV) - A MEETING REPORT OF THE WHO PROGRAM FOR VACCINE DEVELOPMENT [J].
CROWE, JE .
VACCINE, 1995, 13 (04) :415-421